Introducing BiDHA Tablets – A New Approach for Alcohol Use Disorder Management by Swizing Biosciences

Better Tolerance | Better Recovery | Better Life |

Balancing Brain Chemicals for Recovery

Balancing Brain Chemicals for Recovery
Swizing Biosciences proudly introduces BiDHA Tablets, an advanced formulation designed to support the management of Alcohol Use Disorder (AUD). Developed with a commitment to quality, innovation, and patient care, BiDHA Tablets provide healthcare professionals with a trusted treatment option to support long-term recovery when used as part of a comprehensive treatment program.

Alcohol Use Disorder is a chronic medical condition that affects millions of people worldwide. Successful recovery often requires a combination of medication, counselling, behavioural therapy, and lifestyle modifications. BiDHA Tablets are formulated to support patients on their recovery journey by helping restore the balance of important brain chemicals disrupted by long-term alcohol dependence.

GABA & Glutamate Balance to Help Reduce Craving

Long-term alcohol use disrupts the balance between two important neurotransmitter systems—GABA (Gamma-Aminobutyric Acid) and Glutamate. This imbalance can contribute to cravings and make it more difficult to maintain abstinence after stopping alcohol.

The active ingredient is, Acamprosate Gastro-Resistant Tablets BP, helps modulate these neurotransmitter systems and supports recovery by restoring neurochemical balance. When prescribed by a healthcare professional and combined with psychosocial support, BiDHA Tablets can help reduce the likelihood of returning to alcohol use.

Composition of BiDHA Tablets

Acamprosate Gastro-Resistant Tablets BP

Packaging

Pack Size: 10 × 1 × 10 Tablets

Why choose Bidha Tablets ?

Why Choose BiDHA Tablets?
Gastro-Resistant formulation for effective delivery.
Gentle on the stomach for improved patient comfort.
Supports recovery as part of a comprehensive Alcohol Use Disorder treatment plan.
Proven and trusted therapy with an established role in maintaining abstinence when prescribed appropriately.

Swizing Brings New Innovation with BiDHA Tablets

At Swizing Biosciences, innovation is driven by a commitment to improving patient care. With the launch of BiDHA Tablets, we continue to deliver high-quality pharmaceutical solutions that meet evolving healthcare needs. Manufactured under stringent quality standards, BiDHA Tablets reflect our dedication to safety, reliability, and therapeutic excellence.

By combining scientific innovation with trusted quality, BiDHA Tablets support healthcare professionals with an evidence-based treatment option for appropriate patients. Swizing Biosciences remains committed to developing innovative pharmaceutical solutions that contribute to better patient outcomes and long-term recovery. Every stage of the product’s development is guided by stringent quality standards and modern manufacturing practices. This commitment ensures that BiDHA Tablets meet the expectations of healthcare professionals who value reliable and high-quality pharmaceutical solutions.

At Swizing Biosciences, innovation is driven by continuous research, advanced formulation development, and an unwavering commitment to improving healthcare. The company strives to deliver products that align with evolving clinical needs while maintaining the highest standards of safety and quality.

As healthcare continues to advance, BiDHA Tablets represent Swizing Biosciences’ vision of supporting better patient care through trusted pharmaceutical solutions. With a focus on quality, innovation, and long-term healthcare excellence, the company remains dedicated to contributing to improved patient outcomes and overall well-being.Every stage of the product’s development is guided by stringent quality standards and modern manufacturing practices. This commitment ensures that BiDHA Tablets meet the expectations of healthcare professionals who value reliable and high-quality pharmaceutical solutions.

At Swizing Biosciences, innovation is driven by continuous research, advanced formulation development, and an unwavering commitment to improving healthcare. The company strives to deliver products that align with evolving clinical needs while maintaining the highest standards of safety and quality.

As healthcare continues to advance, BiDHA Tablets represent Swizing Biosciences’ vision of supporting better patient care through trusted pharmaceutical solutions. With a focus on quality, innovation, and long-term healthcare excellence, the company remains dedicated to contributing to improved patient outcomes and overall well-being.

Disclaimer

BiDHA Tablets (Acamprosate Gastro-Resistant Tablets BP) are prescription medicines and should be used only under the supervision of a registered healthcare professional. The information provided is intended for educational purposes only and should not be considered medical advice . BiDHA Tablets are most effective when used as part of a comprehensive treatment program that includes counselling and psychosocial support. Please refer to the approved prescribing information before use.

Contact Swizing Biosciences Today

For product inquiries, PCD Pharma Franchise opportunities, distributorship, or bulk orders, we’re here to help.

Call us now: +91 95920 87880

Visit our website: www.swizingbiosciences.com

Email us at: swizbio@gmail.com

Partner with Swizing Biosciences — and grow with quality healthcare solutions.